The Economics of Essential Medicines

Brigitte Granville

Royal Institute of International Affairs, 2002 - Business & Economics - 300 pages

This volume highlights the pressing issue of the availability of essential medicines in developing countries. It includes perspectives from developed and developing countries, the public and the private sector, and health service delivery, as well as research and development issues.Contributors include Keith Maskus (University of Colorado), Jayashree Watal (Intellectual Property Division, WTO), Owen Lippert (Fraser Institute, Canada Oxfam Paper), Harvey Bale (International Federation of Pharmaceutical Manufacturers Association), Jorge A.Z. Bermudez (National School of Public Health, Oswaldo Cruz Foundation, Brazilian Ministry of Health), Dorothy Ochola (UNAIDS/Ministry of Health HIV/AIDS Drug Access Initiative, Uganda), Jillian Cohen, World Bank-PAHO Pharmaceuticals Liaison Officer), Duncan Reekie (University of the Witwatersrand, South Africa), Jeffrey L. Sturchio (Merck & Company), Markus Haacker (IMF), Andrew Creese (World Health Organization), and Louisiana Lush (London School of Hygiene and Tropical Medicine).

Contents

• A Market Perspective on Recent Developments in the TRIPS: 3
• Assessing the longterm dynamic gains: 23
• The Economics of TRIPS Options for Access to Medicines: 32

About the author

Brigitte Granville is a professor of international economics and economic policy at the Centre for Business Management, Queen Mary, University of London and former head of the International Economics Programme at RIIA.

Bibliographic information

• Title: The Economics of Essential Medicines; International economics programme; The Economics of Essential Medicines, Brigitte Granville
• Editor: Brigitte Granville
• Edition: illustrated
• Publisher: Royal Institute of International Affairs, 2002
• ISBN: 186203138X, 9781862031388
• Length: 300 pages
• Subjects: Business & Economics / Industries / General